Kamp, K.

patient insulinoma tumor hypoglycemia liver treatment insulin somatostatin metastase octreotide therapy month neuroendocrine liver metastases glucose cycle receptor endocrinol diagnosis control 8- wk intervals radiolabeled somatostatin analogs /liter pancreatic pancreas disease metastatic analog neuroendocrine tumors metab diazoxide blood glucose levels iv glucose lymph interval grade metastatic insulinomas ki -67 index activity episode effect radiolabeled octreotide sc ct scans insulinoma pancreas sc octreotide level blood yr-old pancreatic neuroendocrine tumors november plasma fasting abdomen -67 herder ww chemotherapy kwekkeboom dj valkema r kwekkeboom histological examination progression peptide sst 2a tumor progression inhibitor uptake everolimu table study herder krenning center mtor inhibitors co-worker radionuclide lesion euglycemia kidney function tests insulinoma patients